Human Cardiac Primary cells

Human Cardiac Primary cells

Human cardiac primary cells are cells isolated directly from human cardiac tissue and used as in vitro models of human cardiovascular biology. Depending on the cell type and source, they may be supplied freshly isolated, cryopreserved, or after limited ex vivo expansion. The adult human heart contains diverse cellular populations, including cardiomyocytes, cardiac fibroblasts, endothelial cells, vascular smooth muscle cells, pericytes, and immune cells. Their interactions contribute to myocardial structure and function, extracellular-matrix organization, vascular homeostasis, tissue repair, and cardiac remodeling.

Compared with immortalized cell lines, primary cardiac cells can retain more donor- and tissue-specific phenotypic characteristics, although their properties are influenced by donor age, disease status, anatomical region, isolation procedures, and culture conditions. Cardiac fibroblasts are particularly heterogeneous and can exhibit distinct phenotypic and activation states depending on developmental and pathological context.

Key Features

  • Human-Derived Cardiac Cell Populations : Includes cardiomyocytes, cardiac fibroblasts, endothelial cells, and other cardiac-associated cells, depending on tissue source.

  • Physiologically Relevant Cellular Models: Suitable for studying cell–cell communication, extracellular-matrix interactions, cardiac remodeling, and disease-associated cellular phenotypes.

  • Versatile Culture Applications : Suitable for selected 2D and 3D culture, co-culture, tissue-engineering, and multicellular cardiac model applications.

Usual Research Applications

  • Cardiovascular disease research, including cardiac fibrosis, hypertrophy, heart failure, and myocardial injury.

  • Investigation of cardiac signaling, fibroblast biology, endothelial–cardiac cell interactions, extracellular-matrix remodeling, and disease-associated phenotypes.

  • Development and characterization of engineered cardiac tissues and multicellular in vitro cardiac models, including selected microphysiological and heart-on-chip platforms.